Gilead Sciences (GILD) Tops Q3 EPS by 94c
Tweet
Share
E-mail
Get Alerts GILD Hot Sheet
Price: $131.27 +4.21%
EPS Growth %: -464.2%
Financial Fact:
Shares used in per share calculation - basic: 1.32B
Today's EPS Names:
CRMT, More
EPS Growth %: -464.2%
Financial Fact:
Shares used in per share calculation - basic: 1.32B
Today's EPS Names:
CRMT, More
Join SI Premium – FREE
Gilead Sciences (NASDAQ: GILD) reported Q3 EPS of $2.65, $0.94 better than the analyst estimate of $1.71. Revenue for the quarter came in at $7.4 billion versus the consensus estimate of $6.18 billion.
GUIDANCE:
Gilead Sciences sees FY2021 EPS of $7.90-$8.10, versus the consensus of $7.18. Gilead Sciences sees FY2021 revenue of $26-26.3 billion, versus the consensus of $25.12 billion.
For earnings history and earnings-related data on Gilead Sciences (GILD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trump said he was unaware of his earnings from crypto
- Six Flags names Mark Pauls as chief operating officer
- Pembina joins proposed 1M bbl/day Alberta-to-coast pipeline plan
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
